Randomized, controlled trial of natural interferon-α therapy for e-antigen-positive chronic haptitis B patients

Hepatology Research

Volumn 23, Issue 2, 2002, Pages 98-104

  Arase, Yasuji ^a   Tsubota, Akihito ^a   Saitoh, Satoshi ^a   Suzuki, Yoshiyuki ^a   Kobayashi, Masahiro ^a   Suzuki, Fumitaka ^a   Someya, Takashi ^a   Akuta, Norio ^a   Ikeda, Kenji ^a   Kobayashi, Mariko ^a   Kumada, Hiromitsu ^a  

^a TORANOMON HOSPITAL   (Japan)

Author keywords

e Antigen positive chronic hepatitis B; Hepatitis B virus DNA; Interferon

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; ANTIVIRUS AGENT; CORTICOSTEROID; HEPATITIS B(E) ANTIGEN; IMMUNOSUPPRESSIVE AGENT; VIRUS DNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BRANCHED DNA SIGNAL AMPLIFICATION ASSAY; CHRONIC HEPATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA DETERMINATION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; ENZYME IMMUNOASSAY; FEMALE; HEPATITIS B; HUMAN; LONG TERM CARE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 0036627136     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6346(01)00169-3     Document Type: Article

References (20)

1. Akikawa T, Aairenji H, Furuta S, et al. Seroconversion from hepatitis B e antigen to anti-HBe in acute hepatitis B virus infection. N Engl J Med 1978;298:439.
2. Realdi G, Alberti A, Rugge M, et al. Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection. Gastroenterology 1980;79:195-9.
3. Hoofnagle JH, Dusheiko GM, Seeff LB, Jones EA, Waggoner JG, Bales ZB. Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis. Ann Intern Med 1981;94:744-8.
4. Lam KC, Lai CL, Trepo C, Wu PC. Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis. N Engl J Med 1981;304:380-6.
5. Korenman J, Baker B, Waggoner J, Everhart JE, Di Bisceglie AM, Hoofnagle JH. Long-term remission of chronic hepatitis B after alpha-interferon therapy. Ann Intern Med 1991;114:629-34.
6. Tine F, Liberati A, Graxi A, Almasio P, Pagliaro L. Interferon treatment in patients with chronic hepatitis B: A meta-analysis of the published literature. J Hepatol 1993;18:154-62.
7. Hoofnagle JH, Di Bisceglie AM. The treatment of chronic viral hepatitis. N Engl J Med 1997;336:347-56.
8. Niederau C, Heintges T, Lange S, et al. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B. N Engl J Med 1996;334:1422-7.
9. Gregorio GV, Jara P, Hierro L, et al. Lymphoblastoid interferon alfa with or without steroid pretreatment in children with chronic hepatitis B: a multicenter controlled trial. Hepatology 1996;23:700-7.
10. Lok AS, Lai CL, Wu PC, et al. Long-term follow-up in a randomized controlled trial of recombinant alpha 2-interferon in Chinese patients with chronic hepatitis B infection. Lancet 1988;2:298-302.
11. Lok AS, Lai CL, Wu PC, et al. Alpha-interferon treatment in Chinese patients with chronic hepatitis B. J Hepatol 1990;11:121-5.
12. Yokosuka O, Omata M, Imazeki F, et al. Changes of hepatitis B virus DNA in liver and serum caused by recombinant leukocyte interferon treatment: analysis of intrahepatic replicative hepatitis B virus DNA. Hepatology 1985;5:728-34.
13. Kanai K, Kako M, Aikawa T, et al. Twenty-four week administration of recombinant interferon alfa 2a for chronic hepatitis B. Acta Hepat Tap 1998;39:62-7 in Japanese.
14. Arase Y, Chayama K, Ikeda K, et al. Randomized controlled clinical trial of lymphoblastoid interferon-alpha for chronic hepatitis C. Hepatol Res 2001;21:55-66.
15. Arase Y, Chayama K, Tsubota A, et al. A randomized, double-blind, controlled trial of natural interferon-beta therapy for e-antigen-negative chronic hepatitis B patients with abnormal transaminase levels. J Gastroenterol 1996;31:559-64.
16. Usuda S, Okamoto H, Iwanari H, et al. Serological detection of hepatitis B virus genotypes by ELISA with monoclonal antibodies to type-specific epitopes in the pre S2-region product. J Virol Meth 1999;80:97-112.
17. Desmet VJ, Gerber M, Hoofnagle JH, et al. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994;19:1513-20.
18. SAS Institute Inc: SAS/STAT User's Guides, Release 6.03 Edition. Cary, NC, USA, 1998.
19. Ikeda K, Saito S, Suzuki Y, et al. Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients. J Hepatol 1998;28:930-8.
20. Kao JH, Wu NH, Chen PJ, et al. Hepatitis B genotypes and the response to interferon therapy. J Hepatol 2000;33:998-1002.